← Back to headlines
David Einhorn Trims Stakes in Teva and Kyndryl
Investor David Einhorn's firm has reportedly trimmed its holdings in Teva Pharmaceutical Industries Limited and Kyndryl Holdings Inc. This move suggests a strategic reduction in exposure to these two companies.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Hungary’s Paks Nuclear Plant Returns to Full Power Output Ahead of Schedule
18m ago
Jennifer Garner Reveals Career Anxiety and Financial Fears Following Divorce
26m ago
Nigerian Government and Student Union Criticize Atiku’s Push to Restore Fuel Subsidies
48m ago
Meta Agrees to $18 Billion Settlement in Child Social Media Addiction Lawsuits
54m ago